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Abstract
We sought to determine whether ambient air pollution is associated with interstitial lung 
abnormalities (ILA) and high attenuation areas (HAA), which are qualitative and quantitative 
measurements of subclinical ILD on computed tomography.
We performed analyses of 6813 community-based dwellers enrolled in the Multi-Ethnic Study of 
Atherosclerosis (MESA), a U.S.-based prospective cohort study. We used cohort-specific 
spatiotemporal models to estimate predictions of ambient pollution (PM2.5, NOx, NO2 and O3) at 
each home. Participants underwent serial assessment of HAA by cardiac CT-scan and a subset of 
participants was assessed for ILA using full lung CT scan at 10 year follow-up. We used 
multivariable logistic regression and linear mixed models adjusted for age, sex, ethnicity, 
education, tobacco use, scanner technology and study site.
The odds of ILA increased 1.62-fold per 40ppb increment in NOx (95%CI 0.97 to 2.71, p-value 
0.06), and were strongest in non-smokers (2.60-fold increase per 40ppb increment in NOx, 95% CI 
1.20 to 5.61, p-value 0.02). HAA increased by 0.54% per year per 5μg/m3 increment in PM2.5 
(95%CI 0.02% to 1.10%, p-value 0.04) and by 0.55% per year per 40ppb increment in NOx 
(95%CI 0.08% to 1.00%, p-value 0.02).
Ambient air pollutants were associated with measurements of subclinical ILD.
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Introduction
Air pollution is a risk factor for adverse respiratory outcomes. Many studies have shown 
associations between pollution exposure and the incidence and/or progression of multiple 
pulmonary diseases, including asthma,1 COPD,2 bronchiectasis,3 respiratory infections,4 
chronic lung allograft dysfunction5 and lung cancer.6 There has been little research on 
whether air pollution may contribute to the etiology or accelerate the progression of 
interstitial lung diseases (ILDs), a heterogeneous group of chronic lung diseases 
characterized by inflammation and fibrosis of the pulmonary parenchyma that affect nearly 1 
out of 200 older adults in the U.S.7
ILD is often diagnosed after the onset of irreversible parenchymal fibrosis. Early symptoms 
are nonspecific and frequently attributed to other chronic pulmonary or cardiac diseases. 
Due to the late presentation of clinical manifestations and the presumed long latency 
between exposure and disease development, the underlying etiologies of many of the ILDs 
are unknown.
The growing recognition and identification of subclinical forms of ILD on CT scan provides 
a unique opportunity to investigate antecedent causes, rather than consequences, of ILD. 
Interstitial lung abnormalities (ILA), a visual assessment of early interstitial changes in 
nondependent portions of the lung, is a well validated qualitative measurement of subclinical 
ILD.8 A quantitative CT attenuation-based phenotype of subclinical ILD, termed high 
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attenuation areas (HAA), has also been shown to be a marker of subclinical lung 
inflammation and fibrosis.9–11 Longitudinal studies estimate that 20% to 46% of participants 
with ILA have progressive imaging abnormalities, with approximately 4% developing 
features of usual interstitial pneumonia (UIP).12 Even in the absence of clinical ILD, 
populations with subclinical ILD have more respiratory symptoms, physiologic decrements 
and higher mortality.10,13,14 Inhalational exposures underlie the pathobiology of asbestosis, 
hypersensitivity pneumonitis and smoking-related ILDs. Ambient air pollutants may initiate 
or contribute to the cycle of alveolar injury, disordered repair and fibrosis seen in the ILDs, 
and have been associated with clinical exacerbations in interstitial fibrosis patients.15 Air 
pollutants, including fine and ultrafine particles and traffic-related gases, can deposit 
throughout the airways and alveoli, causing either direct damage or triggering inflammation 
and oxidative stress. This could potentially result in alveolar cell injury or senescence, 
endothelial dysfunction, mononuclear cell interstitial inflammation and fibroblast 
proliferation.
The association between air pollutants and ILD has not been previously investigated in a 
population-based study. We hypothesized that exposure to air pollution would be associated 
with qualitative and quantitative measurements of subclinical ILD in community-dwelling 
adults.
METHODS
Study design and participants
The Multi-Ethnic Atherosclerosis Study (MESA) is a prospective cohort study funded by the 
National Heart Lung and Blood Institute to investigate subclinical cardiovascular disease. 
MESA and ancillary studies, MESA Lung and Air, are described in depth elsewhere and 
served as the sampling frame for this study.10,16 Informed consent was obtained for all 
participants and the study was approved by the Institutional Review Board at collaborating 
centers.
Briefly, MESA enrolled 6,814 participants, ages 45–84 from six centers around the US: 
Baltimore, MD; Chicago, IL; Los Angeles County, CA; New York City, NY; St Paul, MN; 
and Winston Salem, NC. By study design, all participants were free of known cardiovascular 
disease at the start of the study; there were no selection criteria based on lung disease, 
respiratory symptoms or smoking history. Participants were recruited between 2000 through 
2002, and underwent questionnaires regarding demographics, family history, medical history 
and lifestyle habits. At enrollment and during the four subsequent exams, participants had 
noninvasive assessment of cardiovascular status including cardiac CT scans - which image 
approximately 70% of the lung volume from main carina to lung. By design, all returning 
participants had a repeat cardiac CT scan at either exam 2 or 3, and 30% of the cohort had a 
third cardiac CT scan at exam 4. An additional subset of 3,137 participants underwent full 
lung or cardiac CT scan at exam 5.
The sampling scheme of participants that were included in our study is described in detail in 
the Supplementary Appendix.
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Interstitial Lung Abnormalities
Full lung MESA CT scans were acquired in years 2010–12 (10-year follow-up) at suspended 
full inspiration using the MESA Lung/SPIROMICS protocol and images were reconstructed 
using 0.625 mm slice thickness.17 One of five board-certified radiologists (inter-reader 
kappa 0.47 (0.14–0.80)) reviewed the full lung CT scans for ILA, which was defined as any 
scan read as “definite” ILD or “suspicious” for ILA. “Definite” ILD was defined as bilateral 
fibrosis in multiple lobes associated with honeycombing and traction bronchiectasis in a 
subpleural distribution. Scans were read as “suspicious” for ILA in the presence of ground-
glass, reticular abnormality, diffuse centrilobular nodularity, honeycombing, traction 
bronchiectasis, non-emphysematous cysts or architectural distortion in at least 5% of 
nondependent portions of the lung.18 Scans with solitary abnormalities that appeared in less 
than 5% of the lungs were read as “equivocal” for ILA and were excluded from the main 
analysis, as previously has been described.10 In a sensitivity analysis, these “equivocal” 
scans were included in the group of participants without ILA.
High Attenuation Areas
HAA was measured on non-contrast cardiac CT scans performed at the MESA baseline visit 
and selected follow up exams using highly standardized protocols.19 A prior validation study 
using MESA full lung scans showed that cardiac CT scans image approximately 65–70% of 
the total lung volume, capturing most of the lower lobes and excluding much of the lung 
apexes. Quantitative image attenuation was measured by trained readers using a modified 
version of the Pulmonary Analysis Software at the University of Iowa Imaging Lab (Iowa 
City, IA, USA) (intra-class correlation 0.93).9 HAA was defined as the percent of the 
imaged lung volume having attenuation values between −600 and −250 Hounsfield Units 
(HU).9,10 This range of CT lung attenuation includes ground-glass and reticular 
abnormalities, and excludes denser areas such as atelectasis, medium and large blood vessels 
and pulmonary nodules. Percent emphysema was defined as the percentage of voxels below 
−950 HU.
Exposure assessment
Ambient air pollution exposure was estimated for each participant using residential history 
data (reported from 1980–2012) and spatio-temporal prediction models based on land use 
regression and geostatistical smoothing. These validated models are described in detail 
elsewhere.20,21
In brief, pollutants were measured at 27 long-term sites, 771 community snapshots and 
outside 697 participant homes between 2005–2009. Using these measurements to 
supplement pollution monitoring from the monitoring locations in the EPA Air Quality 
System, MESA Air developed community-specific spatio-temporal models incorporating 
geographic information and spatial smoothing. These models predict pollutant 
concentrations at residences for each two-week period between 1999–2012 and explain 90–
97% of the variation in measurements at participant homes.
Given the expectation of a prolonged period of exposure contributing to the development of 
ILA, we estimated long-term ambient pollution exposure using ten-year averages of two-
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week, residence-specific predictions prior to full lung CT scan. As a sensitivity analysis, we 
estimated twenty and thirty year exposure to PM2.5 prior to full lung CT scan based on 
historic models of annual average exposure developed for periods pre-dating intensive PM 
monitoring.22 These long-term residential estimates used address-weighted averages of 
annual PM2.5 concentration.
To model the progression of HAA, we estimated long-term exposures as the average of two-
week residence-specific predictions from recruitment to follow-up. Year 2000 concentrations 
at participant’s address at recruitment were used to model the baseline cross-sectional 
relationship.
Statistical Analyses
All statistical tests were performed in SAS version 9.3 (SAS Institute) using a two-tailed α= 
0.05 to define statistical significance.
We used multivariable logistic regression to examine the associations between predicted 10-
year pollutant exposures and the odds of ILA on full lung CT scan at exam 5. Models were 
adjusted for age, gender, ethnicity, tobacco use (current smoking status and pack years) and 
site. In the main analysis, participants with “equivocal” ILA were excluded from the analysis 
and in a sensitivity analysis these participants were included in the group of participants 
without ILA. Sensitivity sub-analysis was performed with additionally adjustment for 
occupational exposures, a well-established risk factor for ILD. Occupational exposure was 
defined according to a previously developed and applied job exposure matrix (JEM) 
quantifying exposure to vapors, gas, dusts and fumes, but was not available for all 
participants.23 Sensitivity analyses were performed using longer exposure periods by 
averaging 20 and 30-year estimates of PM2.5 derived from historic models pollution 
estimates when available. Other studies have shown differential effects on subclinical ILD 
based on smoking status, ethnicity and gender, so a priori, we decided to test for effect 
modification by these variables.9,11 Where stratified models showed different magnitudes of 
associations, we additionally tested for effect modification with a multiplicative interaction 
between pollutants exposure and potential effect modifier. We used the likelihood ratio test 
between the nested main effect and multiplicative models to test for statistical significance.
Linear mixed models were used to analyze the cross-sectional associations between air 
pollution and HAA at baseline examination and between air pollution and the rate of 
progression of HAA. HAA was log transformed in the model, and back transformed to 
obtain estimates of percent change. Repeated measurements were modeled as a function of 
study time, with time-varying exposures modeled as an interaction with time to examine 
associations between pollutant exposure and the linear rate of change of HAA over time. 
Participant-specific random intercepts and slopes were included. Models were adjusted for 
age, gender, race/ethnicity, educational attainment, JEM, height, BMI, waist circumference, 
smoking status, cigarette pack-years, glomerular filtration rate, total volume of image lung, 
percent emphysema on CT scan, CT scanner type and study site. Potential effect 
modification was examined by stratification on smoking status, gender and ethnicity.
Sack et al. Page 5
Eur Respir J. Author manuscript; available in PMC 2018 December 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
RESULTS
3137 MESA participants, including some of the participants recruited under MESA Air, had 
a full lung CT scan that was assessed by a radiologist. 128 were not read for ILA and 34 had 
unreadable scans. As previously done, we further excluded 491 full lung CT scans that were 
read as “indeterminate” for ILA.10 171 participants were missing ten year-pollutant 
estimates and 48 were missing other covariates, leaving 2265 participants with full lung CT 
scans in our final analysis of ILA (see appendix, figure S1). 6813 MESA participants had a 
baseline cardiac CT scan with valid HAA measurements. Of these, 5965 participants had at 
least one follow up cardiac CT scan during the study. 460 of these participants were missing 
either covariate information or pollutant estimates, leaving 5508 participants that were 
included in the longitudinal analysis of HAA progression (see appendix, figure S2). The 
mean number of cardiac CT scans per participant was 2.4. The mean follow-up time among 
the participants with at least 2 cardiac CT scans was 5.9 years, with a range of 0.9 to 11.4 
years.
Baseline characteristics and air pollution estimates were similar in the cohorts included in 
the ILA and HAA analyses (Table 1). The mean age of the full cohort at baseline was 62 
years (SD 10) and 3214 (47%) were male. Racial/ethnic differences were based on study 
design: 2621 (39%) participants were white, 1893 (28%) were African American, 1496 
(22%) were Hispanic and 803 (11%) were Chinese American. 3085 (45%) participants had 
never smoked and 967 (14%) were current smokers.
Average air pollution concentration decreased over the study time, as described in detail 
elsewhere (16). Mean pollution concentration also varied by site, with the highest levels of 
PM2.5 in Los Angeles and the highest levels of nitrates (NOx and NO2) in New York City. 
Pollutant levels were positively correlated with the exception of O3, which was negatively 
correlated with the other pollutants (see appendix Tables S1 and S2).
Associations of pollutants with Interstitial Lung Abnormalities
310 (9.9%) of the 3137 participants who underwent full lung CT scan had ILA: 289 (9.2%) 
had scans read as suspicious for ILD and 21 (0.67%) had scans that met standard criteria for 
a UIP pattern with bilateral fibrosis associated with honeycombing and traction 
bronchiectasis in a subpleural distribution. In multivariable-adjusted analyses, there were no 
significant associations between pollutant exposure and ILA in the overall analyses (Table 2; 
Figure 1). The odds of ILA increased 1.62-fold per 40ppb increment in NOx (95%CI 0.97 to 
2.71, p-value 0.06). In the a priori specified group of non-smokers, greater exposure to NOx 
and NO2, and lesser exposure to O3 were each associated with an increased odds of ILA. 
Each 40 ppb increment in in NOx was associated with a 2.6-fold greater odds of ILA (95% 
CI 1.20 to 5.61, p-value 0.02; p-value = 0.21 for interaction with smoking, appendix Table 
S4), while each 10 ppb increment in O3 was associated with an odds ratio for ILA of 0.33 
(95% CI 0.10 to 1.05, p-value 0.06; p-value = 0.27 for interaction with smoking, appendix 
Table S5).
In the sensitivity analysis which included participants with a CT scan initially read as 
“equivocal” in the control group of participants without ILA, associations between 
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pollutants and ILA were more robust (see appendix Table S5). For example, in this 
sensitivity analysis, the odds of ILA increased to 1.77-fold per 40ppb increment in NOx 
(95%CI 1.06 to 2.95, p-value 0.03). Additional adjustment for occupational exposures led to 
similar findings (see appendix Table S6). Effect estimates were strongest among non-
Hispanic whites, where there was a 3.13-fold increase in odds of ILA (95%CI 1.00 to 9.86, 
p-value 0.05; p-value = 0.9 for interaction between NOx and non-Hispanic white) per 40ppb 
increase in NOx exposure. Sensitivity analyses with 20 and 30-year pollutant estimates using 
a historic model for PM2.5 yielded comparable qualitative results (see appendix Table S7).
Association with High Attenuation Areas
At recruitment, MESA participants had a mean HAA of 5.1% (3.1% SD) with a range of 
1.4% to 46.6%. HAA decreased by an average of 0.35% (95% CI 0.21% to 0.48%) per year 
during the study time. In the primary analysis adjusted for potential confounders (Table 2), a 
5μg/m3 increase in PM2.5 concentration was associated with a 0.54% (95% CI 0.02% to 
1.10%, p-value 0.04) increase in HAA per year; a 40 ppb higher NOx concentration was 
associated with a 0.55% (95%CI 0.08% to 1.0%; p-value 0.02) increase in HAA per year. 
Effect estimates for NO2 concentration and progression of HAA were in a similar direction. 
There was a negative trend in the association between O3 and HAA, however, this was 
inconsistent in subgroup analyses. There were no consistent cross-sectional associations 
between year 2000 pollution estimates and HAA (see Table S3 in online supplement).
DISCUSSION
We found that exposure to ambient nitrogen oxides was associated with a higher prevalence 
of ILA among non-smokers and with progression of HAA among both smokers and non-
smokers. In addition, greater ambient PM2.5 exposure was associated with HAA 
progression. While less consistent, there was a trend towards an inverse association between 
greater O3 concentrations and subclinical ILD. Ours is the first study to link air pollution 
with early evidence of lung inflammation and fibrosis on CT in community-dwelling adults, 
adding insight into the hypothesis that air pollution could contribute to ILD. The 
associations we found were strongest and most consistent for nitrogen oxide (NOx), which is 
predominantly a mixture of nitrogen monoxide (NO) and nitrogen dioxide (NO2). These 
results are similar to those of Johannson et al., in the sole prior study on the impact of air 
pollution on ILD.15 In a longitudinal study of 436 patients with idiopathic pulmonary 
fibrosis (IPF) from Seoul, South Korea, the authors showed that higher levels of NO2 over 
the previous six weeks were associated with increased risk of an IPF exacerbation. 
Epidemiologic studies have also established the importance of nitrate exposure with other 
respiratory conditions, including reduced lung function,24 asthma25 and COPD.26
NOx levels are highest in the near road environment, and may serve as a proxy for a suite of 
other traffic-related air pollutants (TRAP), including polyaromatic carbons, ultra-fine 
particles and other products of fossil fuel combustion. In comparison, O3 tends to be lower 
in the near road environment – both due to O3 scavenging by traffic-produced NO and 
because O3 is a secondary pollutant, which is photochemically produced in the troposphere 
by the reaction of sunlight on volatile compounds.27 This negative correlation could be 
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responsible for the trend towards an inverse effect that we saw with higher levels of O3. 
During inhalation, NOx and TRAP combine with ammonia and other small particles, to 
penetrate deep within the bronchial tree. While there is some absorption throughout the 
respiratory tract, the primary site of injury is at the terminal bronchioles where particles can 
be phagocytized by airway macrophages, activate pulmonary nocioceptive fibers or cause 
direct epithelial damage.28 Mediated by the formation of reactive oxygen species, this leads 
to airway and systemic inflammation with ongoing cytokine and chemokine release. Murine 
models have demonstrated that nitrate exposure causes cellular injury, epithelial 
proliferation, hyperplasia, inflammation and fibrotic changes.29 In genetically susceptible 
humans, this could potentially initiate or contribute to the cycle of alveolar injury, disordered 
repair and fibrosis seen in the ILDs.
Our ILA findings were strongest in never smokers, a finding similar to other studies that 
have also reported pollution-related health effects predominantly in non-smokers.30 Previous 
authors have postulated that the detrimental effects of cigarette smoke may overwhelm the 
adverse consequences of ambient air pollution exposure.30 A similar phenomenon may drive 
the suggestion of a differential effect that we observed in ethnic groups with stronger effects 
from unmeasured healthcare disparities and other confounders compared to the effects due 
to air pollution. While our study had enough power to assess for associations with our main 
outcome of interest, our ability to show effect modification by these variables is limited.
The effect sizes we observed due to air pollution were small, but represent important 
subclinical changes in the lungs of asymptomatic community-dwelling U.S adults. We used 
sophisticated modelling to produce individual estimates of long-term exposure to air 
pollution, and investigated the effect of different lag times of exposure. By adjusting for site, 
we were able to eliminate unmeasured confounders between cities and focus on within city 
variations in pollutant levels.
This was an observational study with inherent limitations of exposure and outcome 
misclassification, residual confounding and the inability to infer causation. The longer term 
estimates of particulate matter exposure (twenty and thirty years) that were derived from 
historic models may be less accurate than our other pollutant estimates, which did not 
extrapolate to time periods with limited data and also benefitted from spatially intensive air 
pollution monitoring data. This non-differential exposure classification would be expected to 
weaken the strength of associations with ILA and HAA for the longer exposure periods. Our 
definition of subclinical ILD was based on radiologic findings rather than histologic 
changes. It is possible that our quantitative measurement of lung density included other 
pulmonary processes, such as edema, infection, or atelectasis. However, as described in our 
prior studies of this cohort, there was no evidence of confounding by cardiac function, 
obesity or the percentage of lung imaged.10
In summary, we found that ILA was associated with long-term average exposure to oxides of 
nitrogen among non-smokers, and that HAA progression was associated with exposure to 
both oxides of nitrogen and fine particulates. More epidemiologic and translational studies 
will be needed to investigate the roles of individual pollutants and identify the potential 
biological pathways underlying these associations. Although definitive evidence is still 
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missing, this study provides supporting evidence that air pollution could be a potential risk 
factor for ILD. If proven, this would have important clinical implications for patients and 
serve to help inform public policy.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Predicted risk of Interstitial Lung Abnormalities with increasing levels of pollutants: PM2.5, 
NOx, NO2, O3. Effect estimates are derived from general additive models, with black points 
demonstrating the overall effect estimates and thin dashed lines representing the 95% 
confidence bands. All models adjusted for age, sex, race/ethnicity, tobacco use (pack years, 
smoking status) and study site.
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TABLE 1
Baseline Characteristics of Participants Included in Analyses of Subclinical ILD
HAA Measured at Exam 1+ HAA Cohort ILA Cohort++
Participants (no) 6813 5508 2265
Age (years) 62.2 (10.2) 61.6 (10.1) 59.8 (9.4)
Male 3214 (47.2) 2674 (48.6) 1059 (46.8)
Race
 White 2621 (38.5) 2237 (40.6) 904 (39.9)
 African-American 1893 (27.8) 1516 (27.5) 597 (26.4)
 Hispanic 1496 (22) 1142 (20.7) 455 (20.1)
 Asian (Chinese) 803 (11.8) 613 (11.1) 309 (13.6)
BMI, kg/m2 28.3 (5.5) 28.4 (5.4) 28.2 (5.3)
Height, cm 166.4 (10) 166.9 (10) 166.9 (10)
Weight, lbs 173.4 (38.2) 174.5 (38.0) 173.7 (37.8)
Smoking status
 Never smokers 3085 (45) 2469 (44.8) 1130 (49.9)
 Former smokers 2761 (41) 2268 (41.2) 840 (37.1)
 Current smokers 967 (14) 771 (14.0) 294 (13.0)
 Cigarette pack-years* 13 (2.0–31.5) 13.5 (2.4–31.0) 12.7 (2–30)
Socioeconomic status
Education+
 ≤ high school 2460 (36.2) 1802 (32.7) 681 (30.7)
 Some college 1937 (28.5) 1618 (29.4) 637 (28.8)
 ≥ college 2393 (35.2) 2088 (37.9) 897 (40.5)
Income++
 < 25000 2059 (31.5) 1481 (27.7) 533 (24.2)
 25000–74,999 3003 (45.9) 2554 (47.8) 1084 (49.2)
 ≥ 75000 1478 (22.6) 1309 (24.5) 585 (26.6)
Occupational exposure**
 Low 4913 (76.2) 4250 (77.2) 1681 (78.2)
 Intermediate 1055 (16.4) 863 (15.7) 321 (14.9)
 High 481 (7.5) 395 (7.2) 148 (6.9)
Percent emphysema 4.2 (4.5) 4.2 (4.4) 4.0 (4.0)
Study Site
 Winston Salem, NC 1077 (15.8) 895 (16.3) 414 (18.3)
 New York, NY 1102 (16.2) 946 (17.2) 439 (19.4)
 Baltimore, MD 1086 (15.9) 856 (15.5) 295 (13)
 St. Paul, MN 1066 (15.7) 881 (16.0) 310 (13.7)
 Chicago, IL 1164 (17.1) 987 (17.9) 450 (19.9)
 Los Angeles, CA 1318 (19.4) 943 (17.1) 357 (15.8)
Pollutants+++
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HAA Measured at Exam 1+ HAA Cohort ILA Cohort++
 PM2.5 16.8 (2.8) 16.7 (2.8) 16.5 (2.8)
 NOx 50.7 (27.7) 50.1 (27.5) 48.7 (26.9)
 NO2 21.5 (9.1) 21.3 (9.2) 20.9 (9.1)
 O3 20.2 (4.9) 20.3 (4.9) 20.5 (5.1)
Data presented as mean ± SD, n (%) unless otherwise stated. All parameters collected at MESA baseline visit in years 2000–2002, unless otherwise 
stated. ILA = interstitial lung abnormalities; HAA = high attenuation areas; BMI = body mass index
*
median (interquartile range) among ever smokers
**
exposure to vapors, gas, dust and fumes derived from job exposure matrix; missing in 364 participants with HAA measured at Exam 1, 115 
participants in ILA cohort
+
excludes 1 participant without baseline HAA measurement
++includes demographics from 53 MESA Air new recruits at time of recruitment, with exception of age, which is backdated to year 2000
+
education missing in 23 participants with HAA measured at Exam 1, 50 participants from ILA cohort
++income missing in 273 participants with HAA measured at Exam 1, 164 from HAA cohort, 63 in ILA cohort
+++year 2000 estimates, ppb
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